Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Erlend Petter Skagseth | M | 69 |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | - |
Daniele Scarinci | M | - |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 3 years |
Marija Zecevic | M | 51 |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 1 years |
Paolo Fundarò | M | 50 |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 3 years |
Jeffrey Wager | M | 62 | 3 years | |
Federica Draghi | M | - |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 2 years |
Marit Otterlei | M | 61 |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | 15 years |
Dan Hartman | M | 62 | 3 years | |
Bertil Lindmark | M | 68 |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 1 years |
Victor Savevski | M | - |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 1 years |
Michele Manto | M | - |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 1 years |
Birgitte Gangmark Villmo | F | - |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | - |
Hans Olav Minsås | M | - |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | - |
Stener Kvinnsland | M | 76 |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | - |
Bastiaan van der Baan | M | 52 |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 1 years |
Jørgen André Nilsen | M | 58 |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | - |
Konstantinos Alevizopoulos | M | 54 |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | - |
Keith Dawkins | M | 73 |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 1 years |
Robert Clarke | M | 56 | 3 years | |
Farzaad Abdi-Dezfuli | M | 61 |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | - |
Jonathan Kearsey | M | - |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | - |
Martin Welschof | M | 63 |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | 9 years |
Stephan Wehselau | M | 55 | 3 years | |
Dennis Ausiello | M | 78 | 3 years | |
Juergen Froehlich | M | 68 | 3 years | |
Luca Quagliata | M | - |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jean-Pierre Obrecht | M | - | 24 years | |
Kalina Scott | F | 49 | 2 years | |
Kadri Özgünes | M | 51 |
Bogazici University
| 4 years |
Daniel Obrecht | M | 69 | 25 years | |
Cem Bayulgen | M | - |
Bogazici University
| 5 years |
Cafer Sadik Abalioglu | M | 46 |
Bogazici University
| 2 years |
Sercan Ozcan | M | - |
Bogazici University
| 5 years |
Hernan Levett | M | 49 | 4 years | |
Franziska Müller | F | 42 | 13 years | |
Müzeyyen Münire Gülay Barbarosoglu | M | - |
Bogazici University
| - |
Ferit Erin | M | 45 |
Bogazici University
| 4 years |
Mehmet Fatih Kacir | M | 39 |
Bogazici University
| 4 years |
Kerem Günay | M | - |
Bogazici University
| 4 years |
Osman Basaran | M | - |
Bogazici University
| 4 years |
Elif Satiroglu | F | - |
Bogazici University
| 4 years |
Serdar Kabaca | M | - |
Bogazici University
| 4 years |
Argeris Karabelas | M | 71 | 6 years | |
Kerem Tuzcuoglu | M | - |
Bogazici University
| 5 years |
Melih Poyraz | M | - |
Bogazici University
| 4 years |
Mehmet Ali Nalcacioglu | M | 47 |
Bogazici University
| 1 years |
Eren Saricoglu | M | - |
Bogazici University
| 4 years |
Neset Fatih Vural | M | 44 |
Bogazici University
| 4 years |
Deniz Uyan Ay | M | - |
Bogazici University
| 4 years |
Alper Cumhur Albayrak | M | - |
Bogazici University
| 4 years |
M Rasid Ünal | M | - |
Bogazici University
| 4 years |
Pelin Muslu Satici | F | 42 |
Bogazici University
| 4 years |
Gül Ertug | F | - |
Bogazici University
| 2 years |
Mustafa Çetin Özbudun | M | - |
Bogazici University
| 4 years |
Öner Tekin | M | 46 |
Bogazici University
| 1 years |
Arda Batu | M | - |
Bogazici University
| 4 years |
Nevgul Bilsel Safkan | F | - |
Bogazici University
| 1 years |
Helmut H. Kessmann | M | 64 | 8 years | |
Figen Dogan | M | 46 |
Bogazici University
| 4 years |
Giacomo di Nepi | M | 72 | 4 years | |
Alkan Yerlikaya | M | 47 |
Bogazici University
| 4 years |
Harun Hanne Moreno | M | 64 |
Bogazici University
| 2 years |
Mete Uluyurt | M | 52 |
Bogazici University
| 2 years |
Naim Firat Dernek | M | - |
Bogazici University
| 4 years |
Cenk Ural | M | - |
Bogazici University
| 3 years |
Ilker Saltoglu | M | 51 |
Bogazici University
| 4 years |
Elif Yener | F | 44 |
Bogazici University
| 4 years |
Fulya Kirayoglu | F | - |
Bogazici University
| 4 years |
Beyza Genc | F | 46 |
Bogazici University
| 2 years |
Tugba Tanrikulu Çil | F | 41 |
Bogazici University
| 4 years |
Aytaç Aydin | M | - |
Bogazici University
| 4 years |
Baran Çelik | M | 43 |
Bogazici University
| 4 years |
Hafize Erkan | M | 44 |
Bogazici University
| 4 years |
Meral Eredenk Kurdas | F | - |
Bogazici University
| 1 years |
Eren Günhan Ulusoy | M | 43 |
Bogazici University
| 4 years |
Mustafa Aydin | M | - |
Bogazici University
| 2 years |
Erkan Bulut | M | - |
Bogazici University
| 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
Turkey | 43 | 55.84% |
Switzerland | 14 | 18.18% |
Italy | 10 | 12.99% |
Norway | 10 | 12.99% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gökhan Batur
- Personal Network